Lv63
2370 积分 2022-01-04 加入
Unlocking the potential of T cell engagers in solid tumors
3天前
已完结
The evolving landscape of obesity pharmacotherapy
11天前
已完结
Ribosome Display and Related Technologies
1个月前
已完结
Designing T-cell Engagers: Trade-offs Between Activity and Safety
1个月前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
2个月前
已完结
Targeting peptide–HLA complexes for precision immunotherapy
2个月前
已完结
Clinical Pharmacology Characterization of Bispecific T‐Cell Engagers: A Summary Based on FDA Approvals
2个月前
已完结
The B7-H3 (CD276) pathway: emerging biology and clinical therapeutics
3个月前
已完结
Mammalian Cell Surface Display of Full Length IgG
3个月前
已完结
Selection and Characterization of Antibodies from Phage Display Libraries Against Internalizing Membrane Antigens
4个月前
已完结
皖公网安备34019202002308
